Terms: = Brain cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Diagnosis
28 results:
1. Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial.
Zhao S; Zhang M; Zhang Q; Wu J; Dai H
BMC Cancer; 2024 Jan; 24(1):6. PubMed ID: 38166698
[TBL] [Abstract] [Full Text] [Related]
2. Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline.
Rathmell WK; Rumble RB; Van Veldhuizen PJ; Al-Ahmadie H; Emamekhoo H; Hauke RJ; Louie AV; Milowsky MI; Molina AM; Rose TL; Siva S; Zaorsky NG; Zhang T; Qamar R; Kungel TM; Lewis B; Singer EA
J Clin Oncol; 2022 Sep; 40(25):2957-2995. PubMed ID: 35728020
[TBL] [Abstract] [Full Text] [Related]
3. The kdr (vegfr-2) Genetic Polymorphism Q472H and c-KIT Polymorphism M541L Are Associated With More Aggressive Behaviour in Astrocytic Gliomas.
Zaman N; Dass SS; DU Parcq P; Macmahon S; Gallagher L; Thompson L; Khorashad JS; LimbÄck-Stanic C
Cancer Genomics Proteomics; 2020; 17(6):715-727. PubMed ID: 33099473
[TBL] [Abstract] [Full Text] [Related]
4. Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3-TACC3 Fusion and Recurrent Glioblastoma.
Wang Y; Liang D; Chen J; Chen H; Fan R; Gao Y; Gao Y; Tao R; Zhang H
Oncologist; 2021 Mar; 26(3):173-177. PubMed ID: 32949176
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses.
Zhao B; Wang Y; Wang Y; Chen W; Zhou L; Liu PH; Kong Z; Dai C; Wang Y; Ma W
Aging (Albany NY); 2020 Jul; 12(14):14244-14270. PubMed ID: 32669477
[TBL] [Abstract] [Full Text] [Related]
6. BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma.
Labadie BW; Liu P; Bao R; Crist M; Fernandes R; Ferreira L; Graupner S; Poklepovic AS; Duran I; Maleki Vareki S; Balar AV; Luke JJ
J Transl Med; 2019 Nov; 17(1):386. PubMed ID: 31767020
[TBL] [Abstract] [Full Text] [Related]
7. Phase II study of Dovitinib in recurrent glioblastoma.
Sharma M; Schilero C; Peereboom DM; Hobbs BP; Elson P; Stevens GHJ; McCrae K; Nixon AB; Ahluwalia MS
J Neurooncol; 2019 Sep; 144(2):359-368. PubMed ID: 31292802
[TBL] [Abstract] [Full Text] [Related]
8. Grade III meningioma with gastro-intestinal tract and brain metastases: case report and review of the literature.
Bender L; Lhermitte B; Carinato H; Baloglu S; Helali M; Cebula H; Antoni D; Noel G
World J Surg Oncol; 2019 Apr; 17(1):70. PubMed ID: 30992070
[TBL] [Abstract] [Full Text] [Related]
9. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
[TBL] [Abstract] [Full Text] [Related]
10. Clinical and Molecular Characterization of Adult Glioblastomas in Southern Brazil.
Trevisan P; Graziadio C; Rodrigues DBK; Rosa RFM; Soares FP; Provenzi VO; de Oliveira CAV; Paskulin GA; Varella-Garcia M; Zen PRG
J Neuropathol Exp Neurol; 2019 Apr; 78(4):297-304. PubMed ID: 30840759
[TBL] [Abstract] [Full Text] [Related]
11. Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports.
Négrier S; Moriceau G; Attignon V; Haddad V; Pissaloux D; Guerin N; Carrie C
J Med Case Rep; 2018 Nov; 12(1):351. PubMed ID: 30474572
[TBL] [Abstract] [Full Text] [Related]
12. Spontaneous intracerebral hemorrhage as presentation of atypical central neurocytoma: the role of angiogenesis through the characterization of tumor endothelial cells.
Marfia G; Pirola E; Navone SE; Beretta M; Guarnaccia L; Trombetta E; Franzini A; Rampini P; Campanella R
Histol Histopathol; 2018 Jul; 33(7):665-672. PubMed ID: 29215136
[TBL] [Abstract] [Full Text] [Related]
13. Molecular alterations in pediatric brainstem gliomas.
Porkholm M; Raunio A; Vainionpää R; Salonen T; Hernesniemi J; Valanne L; Satopää J; Karppinen A; Oinas M; Tynninen O; Pentikäinen V; Kivivuori SM
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28792659
[TBL] [Abstract] [Full Text] [Related]
14. Copy Number Profiling of Brazilian Astrocytomas.
Bidinotto LT; Torrieri R; Mackay A; Almeida GC; Viana-Pereira M; Cruvinel-Carloni A; Spina ML; Campanella NC; Pereira de Menezes W; Clara CA; Becker AP; Jones C; Reis RM
G3 (Bethesda); 2016 Jul; 6(7):1867-78. PubMed ID: 27172220
[TBL] [Abstract] [Full Text] [Related]
15. Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas.
Taïeb D; Barlier A; Yang C; Pertuit M; Tchoghandjian A; Rochette C; Zattara-Canoni H; Figarella-Branger D; Zhuang Z; Pacak K; Metellus P
J Neurooncol; 2016 Feb; 126(3):473-81. PubMed ID: 26514359
[TBL] [Abstract] [Full Text] [Related]
16. Neuropilin-1 (NRP-1) and Magnetic Nanoparticles, a Potential Combination for diagnosis and Therapy of Gliomas.
Chen L; Zhang G; Shi Y; Qiu R; Khan AA
Curr Pharm Des; 2015; 21(37):5434-49. PubMed ID: 26377659
[TBL] [Abstract] [Full Text] [Related]
17. Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
Tabouret E; Tchoghandjian A; Denicolai E; Delfino C; Metellus P; Graillon T; Boucard C; Nanni I; Padovani L; Ouafik L; Figarella-Branger D; Chinot O
Oncotarget; 2015 May; 6(13):11664-75. PubMed ID: 25860928
[TBL] [Abstract] [Full Text] [Related]
18. Galectin-3: a novel protein in cerebellar hemangioblastoma.
Al-Salam S; Al-Salam M; Al Ashari M
Int J Clin Exp Pathol; 2013; 6(5):853-61. PubMed ID: 23638216
[TBL] [Abstract] [Full Text] [Related]
19. Magnetic resonance imaging is the preferred method to assess treatment-related skeletal changes in children with brain tumors.
Kaste SC; Kaufman RA; Gajjar A; Broniscer A
Pediatr Blood Cancer; 2013 Sep; 60(9):1552-6. PubMed ID: 23526749
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy and safety of bevacizumab in glioblastomas.
De Fazio S; Russo E; Ammendola M; Donato Di Paola E; De Sarro G
Curr Med Chem; 2012; 19(7):972-81. PubMed ID: 22214463
[TBL] [Abstract] [Full Text] [Related]
[Next]
